StockData
Neuphoria Therapeutics Inc. logo

Neuphoria Therapeutics Inc. (NEUP) income statement

NEUPNasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Sep 18, 2026Score 5/30
$2.27−0.21 (-8.47%)

Close on Nov 17, 2026Market cap $68.24KP/E –Yield –

Neuphoria Therapeutics Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2026

Gross margin
–
Operating margin
-1401.1%
Net margin
-1145.7%
Return on equity, FY2026
-61.7%

Financial strength

Current ratio
27.85
Debt to equity
–
Debt to assets
–
Cash to current liabilities
2625.7%

Valuation

P/E ratio
–
Price to sales
–
Price to book
0.00
Dividend yield
–

See a number that looks wrong?